Darvesh S - Search Results

1

Lipid-lowering agents and the risk of cognitive impairment that does not meet criteria for dementia, in relation to apolipoprotein E status.

Rockwood K, Howlett S, Fisk J, Darvesh S, Tuokko H, Hogan DB, Wolfson C, McDowell I. Rockwood K, et al. Among authors: darvesh s. Neuroepidemiology. 2007;29(3-4):201-7. doi: 10.1159/000111583. Epub 2007 Nov 27. Neuroepidemiology. 2007. PMID: 18043005

2

Retrospective diagnosis of dementia using an informant interview based on the Brief Cognitive Rating Scale.

Rockwood K, Howard K, Thomas VS, Mallery L, MacKnight C, Sangalang V, Darvesh S. Rockwood K, et al. Among authors: darvesh s. Int Psychogeriatr. 1998 Mar;10(1):53-60. doi: 10.1017/s1041610298005146. Int Psychogeriatr. 1998. PMID: 9629524

3

Spectrum of disease in vascular cognitive impairment.

Rockwood K, Howard K, MacKnight C, Darvesh S. Rockwood K, et al. Among authors: darvesh s. Neuroepidemiology. 1999;18(5):248-54. doi: 10.1159/000026219. Neuroepidemiology. 1999. PMID: 10461050

4

Inter-rater reliability of the diagnosis of vascular cognitive impairment at a memory clinic.

Wentzel C, Darvesh S, MacKnight C, Shea C, Rockwood K. Wentzel C, et al. Among authors: darvesh s. Neuroepidemiology. 2000 Jul-Aug;19(4):186-93. doi: 10.1159/000026254. Neuroepidemiology. 2000. PMID: 10859497

5

Estimating the prevalence of dementia in elderly people: a comparison of the Canadian Study of Health and Aging and National Population Health Survey approaches.

Thomas VS, Darvesh S, MacKnight C, Rockwood K. Thomas VS, et al. Among authors: darvesh s. Int Psychogeriatr. 2001;13 Supp 1:169-75. doi: 10.1017/s1041610202008116. Int Psychogeriatr. 2001. PMID: 11892964

6

Butyrylcholinesterase and cognitive function.

Darvesh S, MacKnight C, Rockwood K. Darvesh S, et al. Int Psychogeriatr. 2001 Dec;13(4):461-4. doi: 10.1017/s1041610201007876. Int Psychogeriatr. 2001. PMID: 12003252

7

Relation between butyrylcholinesterase K variant, paraoxonase 1 (PON1) Q and R and apolipoprotein E epsilon 4 genes in early-onset coronary artery disease.

Nassar BA, Darvesh S, Bevin LD, Rockwood K, Kirkland SA, O'Neill BJ, Bata IR, Johnstone DE, Title LM. Nassar BA, et al. Among authors: darvesh s. Clin Biochem. 2002 May;35(3):205-9. doi: 10.1016/s0009-9120(02)00296-5. Clin Biochem. 2002. PMID: 12074828

8

Inhibition of human cholinesterases by drugs used to treat Alzheimer disease.

Darvesh S, Walsh R, Kumar R, Caines A, Roberts S, Magee D, Rockwood K, Martin E. Darvesh S, et al. Alzheimer Dis Assoc Disord. 2003 Apr-Jun;17(2):117-26. doi: 10.1097/00002093-200304000-00011. Alzheimer Dis Assoc Disord. 2003. PMID: 12794390

9

The risk of dementia in relation to statins and other lipid lowering agents.

Rockwood K, Darvesh S. Rockwood K, et al. Among authors: darvesh s. Neurol Res. 2003 Sep;25(6):601-4. doi: 10.1179/016164103101202039. Neurol Res. 2003. PMID: 14503013 Review.

10

Differential effects of lipid-lowering agents on human cholinesterases.

Darvesh S, Martin E, Walsh R, Rockwood K. Darvesh S, et al. Clin Biochem. 2004 Jan;37(1):42-9. doi: 10.1016/j.clinbiochem.2003.09.004. Clin Biochem. 2004. PMID: 14675561

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters